Gilles FREYER, Pr
Hospices Civils de Lyon · HCL - Centre Hospitalier Lyon Sud · Centre Hospitalier Lyon Sud
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Gilles FREYER, Pr as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 09:47 UTC. Open this list on ClinicalTrials.gov
- Ph4NCT07859319 · Evaluation of the Efficacy and Acceptability of a Phytotherapy Combining Devil's Claw, Blackcurrant and Meadowsweet for the Management of Aromatase Inhibitor-induced Arthralgia in Patients Treated for Localized Breast Cancer in the Adjuvant SettingHospices Civils de Lyon · not yet recruiting · Hormone Therapy-induced Arthralgia, Phytotherapy, Symptom Management · principal investigator
- Ph2NCT05183984 · Niraparib With beVAcizumab After Complete cytoreductioN in Patients With ovArian CancerARCAGY/ GINECO GROUP · recruiting · Ovarian Cancer · principal investigator
- Ph3NCT04158362 · Endocrine Therapy With Abemaciclib or Chemotherapy as Initial Metastatic Treatment in ER+/HER2- Breast CancerUNICANCER · active not recruiting · Cancer Metastatic · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 09:47 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.